Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors

NCT07236840 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-02-24

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the feasibility and accuracy of a self-administered remote neurological examination using the "Iskhaa" mobile application in patients with brain tumors aged above 5 years who are able to follow app-based instructions.

The main questions it aims to answer are:

1. Development of a mobile application equipped with symptom assessment and recording videos as patients perform specific neurological tasks.
2. Development and validation of the AI model to detect functional changes and predict subsequent neurological deterioration.

Participants will:

1. Use the Iskhaa mobile application to perform guided self-neurological examinations following pre-recorded video instructions.
2. Complete EORTC QLQ-C30 and BN20 questionnaires for quality of life assessment.
3. Record and upload videos (e.g., speech, walking, limb movements) using their mobile camera for analysis.
4. In Phase 1 (onsite), 100 participants will use the app under supervision to ensure usability and accuracy.
5. In Phase 2 (offsite), 500 participants will use the app independently at home for monthly self-assessments, with reminders and follow-up support.
6. Continue routine clinic visits every 3-6 months and imaging every 6-12 months as per standard clinical care.

The study will compare app-recorded data with physician assessments to determine agreement and validity of remote neurological monitoring using artificial intelligence analysis.

Conditions

  • CNS Tumor
  • Artificial Intelligence (AI)
  • Glioma
  • Digital Health

Interventions

BEHAVIORAL

Neurological assessment

This assessment will include Speech, Cerebellar function and Quality of Life questionnaires using mobile application.

Sponsors & Collaborators

  • Bhabha Atomic Research Centre (BARC), Mumbai

    collaborator UNKNOWN
  • Tata Memorial Centre

    lead OTHER

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-20
Primary Completion
2027-11-01
Completion
2027-11-05

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07236840 on ClinicalTrials.gov